• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯CT术前评估与CT联合MRI术前评估在胰腺导管腺癌患者中生存结局的比较研究

A Comparative Study of Survivor Outcomes between Preoperative Evaluation Using CT Alone and Combined CT and MRI in Patients with Pancreatic Ductal Adenocarcinoma.

作者信息

Lee Ji Eun, Kim Seong Hyun, Lee Soon Jin, Choi Seo-Youn, Lee Sunyoung, Lee Bo Ra

出版信息

Taehan Yongsang Uihakhoe Chi. 2021 May;82(3):638-653. doi: 10.3348/jksr.2020.0078. Epub 2021 Feb 28.

DOI:10.3348/jksr.2020.0078
PMID:36238786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9432452/
Abstract

PURPOSE

To compare the recurrence pattern, disease-free survival (DFS), and overall survival (OS) after curative surgery for pancreatic ductal adenocarcinoma (PDAC) in patients who underwent preoperative evaluation with CT alone or in combination with MRI, and to compare the prognosis according to the first recurrence site.

MATERIALS AND METHODS

We retrospectively evaluated 152 patients who underwent R0 resection of PDAC. Preoperative CT or combined CT and MRI were performed for 103 and 49 patients, respectively. Two radiologists recorded the location and date of the first recurrence in consensus. The recurrence pattern, DFS, and OS were compared between the two groups. OS was analyzed according to the first recurrence site.

RESULTS

In both groups, liver metastasis was the most common recurrence pattern. DFS ( = 0.247) or OS ( = 0.067) showed no significant difference between the two groups. OS according to the first recurrence site was the lowest for liver metastasis, followed by locoregional recurrence ( < 0.001).

CONCLUSION

There were no significant differences in the recurrence pattern, DFS, or OS between patients evaluated with preoperative CT alone or with CT and MRI after curative resection of PDAC. Liver metastasis was the most common tumor recurrence pattern with the lowest OS.

摘要

目的

比较仅接受术前CT评估或接受CT与MRI联合评估的胰腺导管腺癌(PDAC)患者在根治性手术后的复发模式、无病生存期(DFS)和总生存期(OS),并根据首次复发部位比较预后。

材料与方法

我们回顾性评估了152例行PDAC根治性R0切除的患者。分别对103例和49例患者进行了术前CT或CT与MRI联合检查。两名放射科医生就首次复发的部位和日期达成一致记录。比较两组的复发模式、DFS和OS。根据首次复发部位分析OS。

结果

两组中,肝转移都是最常见的复发模式。两组间DFS( = 0.247)或OS( = 0.067)无显著差异。根据首次复发部位,肝转移患者的OS最低,其次是局部区域复发( < 0.001)。

结论

PDAC根治性切除术后,仅接受术前CT评估或接受CT与MRI联合评估的患者在复发模式、DFS或OS方面无显著差异。肝转移是最常见的肿瘤复发模式,且OS最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/7635cfe871a5/jksr-82-638-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/a9ab4a23055e/jksr-82-638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/aafc7df2d075/jksr-82-638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/0416954a5422/jksr-82-638-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/fb20366c6ece/jksr-82-638-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/53aaa5f4cf13/jksr-82-638-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/edb4289858b1/jksr-82-638-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/7635cfe871a5/jksr-82-638-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/a9ab4a23055e/jksr-82-638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/aafc7df2d075/jksr-82-638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/0416954a5422/jksr-82-638-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/fb20366c6ece/jksr-82-638-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/53aaa5f4cf13/jksr-82-638-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/edb4289858b1/jksr-82-638-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5eb/9432452/7635cfe871a5/jksr-82-638-g007.jpg

相似文献

1
A Comparative Study of Survivor Outcomes between Preoperative Evaluation Using CT Alone and Combined CT and MRI in Patients with Pancreatic Ductal Adenocarcinoma.单纯CT术前评估与CT联合MRI术前评估在胰腺导管腺癌患者中生存结局的比较研究
Taehan Yongsang Uihakhoe Chi. 2021 May;82(3):638-653. doi: 10.3348/jksr.2020.0078. Epub 2021 Feb 28.
2
Survival Prediction after Curative Resection of Pancreatic Ductal Adenocarcinoma by Imaging-Based Intratumoral Necrosis.基于影像学的肿瘤内坏死对胰腺导管腺癌根治性切除术后生存的预测
Cancers (Basel). 2022 Nov 18;14(22):5671. doi: 10.3390/cancers14225671.
3
Identification of intratumoral fluid-containing area by magnetic resonance imaging to predict prognosis in patients with pancreatic ductal adenocarcinoma after curative resection.通过磁共振成像识别肿瘤内含液区以预测胰导管腺癌患者根治性切除术后的预后。
Eur Radiol. 2022 Apr;32(4):2518-2528. doi: 10.1007/s00330-021-08328-4. Epub 2021 Oct 20.
4
Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.胰腺导管腺癌:定量 CT 特征与纤维基质分数相关,有助于预测切除术后的结局。
Eur Radiol. 2020 Sep;30(9):5158-5169. doi: 10.1007/s00330-020-06853-2. Epub 2020 Apr 28.
5
Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.增强 CT 分期后行胰腺 MRI 对胰腺导管腺癌患者的评估作用。
Cancer Res Treat. 2019 Jan;51(1):24-33. doi: 10.4143/crt.2017.404. Epub 2018 Feb 5.
6
Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?术前 CT 检查在可手术切除的胰腺腺癌患者中的应用:CT 检查与手术之间的时间间隔是否会影响生存?
Abdom Radiol (NY). 2018 Mar;43(3):620-628. doi: 10.1007/s00261-017-1254-9.
7
Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging Predicts Prognosis after Curative Resection.胰腺导管腺癌:MR 成像的边缘增强预测根治性切除术后的预后。
Radiology. 2018 Aug;288(2):456-466. doi: 10.1148/radiol.2018172331. Epub 2018 Apr 17.
8
Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.胰腺导管腺癌根治性切除术后的复发模式
Eur J Surg Oncol. 2009 Jun;35(6):600-4. doi: 10.1016/j.ejso.2008.12.006. Epub 2009 Jan 7.
9
Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.胰导管腺癌切除术后异时性肺转移的不同临床表现:回顾性研究和文献复习。
World J Gastroenterol. 2017 Sep 21;23(35):6420-6428. doi: 10.3748/wjg.v23.i35.6420.
10
Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.术前肝脏磁共振成像对潜在可切除胰腺癌的辅助作用。
Surgery. 2017 Jun;161(6):1579-1587. doi: 10.1016/j.surg.2016.12.038. Epub 2017 Feb 23.

本文引用的文献

1
Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.增强 CT 分期后行胰腺 MRI 对胰腺导管腺癌患者的评估作用。
Cancer Res Treat. 2019 Jan;51(1):24-33. doi: 10.4143/crt.2017.404. Epub 2018 Feb 5.
2
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌切除术后复发的模式、时间和预测因素。
Ann Surg. 2018 May;267(5):936-945. doi: 10.1097/SLA.0000000000002234.
3
The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography.
肝脏磁共振成像在计算机断层扫描显示可切除胰腺癌患者中的价值。
Singapore Med J. 2016 Jun;57(6):334-8. doi: 10.11622/smedj.2016109.
4
Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns.复发局限于肺部的切除性胰腺导管腺癌比那些具有其他复发模式的患者预后明显更好。
Oncotarget. 2015 Nov 3;6(34):36903-10. doi: 10.18632/oncotarget.5054.
5
Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.漏诊的胰腺导管腺癌:对诊断前磁共振成像早期影像表现的评估
Eur J Radiol. 2015 Aug;84(8):1473-1479. doi: 10.1016/j.ejrad.2015.05.012. Epub 2015 May 18.
6
Pulmonary metastases in pancreatic cancer, is there a survival influence?胰腺癌的肺转移会影响生存率吗?
J Gastrointest Oncol. 2015 Jun;6(3):E48-51. doi: 10.3978/j.issn.2078-6891.2014.114.
7
Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.胰腺癌:从最先进的治疗方法到有前途的新疗法。
Nat Rev Clin Oncol. 2015 Jun;12(6):319-34. doi: 10.1038/nrclinonc.2015.53. Epub 2015 Mar 31.
8
Pattern of first recurrent lesions in pancreatic cancer: hepatic relapse is associated with dismal prognosis and portal vein invasion.胰腺癌首次复发病变模式:肝转移与预后不良及门静脉侵犯相关。
Hepatogastroenterology. 2014 Sep;61(134):1756-61.
9
Pancreatic adenocarcinoma.胰腺腺癌
N Engl J Med. 2014 Sep 11;371(11):1039-49. doi: 10.1056/NEJMra1404198.
10
Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association.胰腺导管腺癌放射学报告模板:腹部放射学会和美国胰腺协会的共识声明。
Gastroenterology. 2014 Jan;146(1):291-304.e1. doi: 10.1053/j.gastro.2013.11.004.